SCHEMBL17880662

SCHEMBL17880662

CN[PH](On1nnc2ccccc21)(N(C)C)N(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
RXFP1 Q9HBX9 1/20 0.44
SLC9A1 P19634 3/20 0.41
KEAP1 Q14145 1/20 0.41
KMT2A Q03164 5/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
HDAC3 O15379 3/20 0.39
HDAC4 P56524 3/20 0.39
HDAC1 Q13547 3/20 0.39
HDAC7 Q8WUI4 3/20 0.39
HDAC2 Q92769 3/20 0.39
HDAC10 Q969S8 3/20 0.39
HDAC11 Q96DB2 3/20 0.39
HDAC8 Q9BY41 3/20 0.39
HDAC6 Q9UBN7 3/20 0.39
HDAC9 Q9UKV0 3/20 0.39
HDAC5 Q9UQL6 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL58561 0.81 TSHR (0.49) TSHRNPSR1RXFP1SLC9A1KEAP1
Fluoride SCHEMBL6346 0.80 TSHR (0.47) TSHRNPSR1RXFP1SLC9A1KEAP1
SCHEMBL936121 0.77 TSHR (0.44) TSHRNPSR1RXFP1SLC9A1KEAP1
SCHEMBL20021609 0.77 TSHR (0.44) TSHRNPSR1RXFP1SLC9A1KEAP1
Fluoride SCHEMBL29274482 0.75 TSHR (0.43) TSHRNPSR1RXFP1SLC9A1KEAP1
Phosphoric Acid SCHEMBL19406123 0.73 HDAC3 (0.42) TSHRNPSR1RXFP1SLC9A1KEAP1
SCHEMBL433711 0.73 TSHR (0.50) TSHRNPSR1RXFP1SLC9A1KEAP1
SCHEMBL16497703 0.73 TSHR (0.53) TSHRNPSR1RXFP1SLC9A1KEAP1
SCHEMBL448453 0.72 HDAC3 (0.41) TSHRNPSR1RXFP1SLC9A1KEAP1
SCHEMBL16004772 0.72 TSHR (0.49) TSHRNPSR1RXFP1SLC9A1KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9593113-B2 Imide and acylurea derivatives as modulators of the glucocorticoid receptor BRISTOL-MYERS SQUIBB COMPANY (US) 2017-03-14 US disclosed
US-9593113-B2 Imide and acylurea derivatives as modulators of the glucocorticoid receptor BRISTOL-MYERS SQUIBB COMPANY (US) 2017-03-14 US disclosed
US-20160185776-A1 IMIDE AND ACYLUREA DERIVATIVES AS MODULATORS OF THE GLUCOCORTICOID RECEPTOR BRISTOL-MYERS SQUIBB COMPANY (US) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160185776-A1 IMIDE AND ACYLUREA DERIVATIVES AS MODULATORS OF THE GLUCOCORTICOID RECEPTOR NFKBIA, IKBKB, NFRKB TSHR 778/4885NPSR1 2783/4885RXFP1 3854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.